OBJECTIVE: To relate medical surveillance outcomes to uranium biomonitoring results in a group of depleted uranium (DU)-exposed, Gulf War I veterans. METHODS: Thirty-two veterans of Gulf War I who were victims of 'friendly fire' involving DU weapons, in whom exposure assessment can accurately be measured, had urine uranium concentrations determined using ICP-MS technology. Clinical laboratory parameters were measured and related to urine uranium concentrations. Data were examined by stratifying the cohort into a low U group, <0.10 mug/g creatinine versus a high U group, >/=0.10 mug/g creatinine and assessing differences between groups. RESULTS: Over a decade after first exposure, soldiers possessing embedded DU fragments continue to excrete elevated concentrations of uranium in urine. No clinically significant uranium related health effects were observed in blood count, blood chemistries including renal markers, neuropsychological measures, and semen quality or genotoxicity measures. Markers of early changes in renal glomerular and tubular function were not statistically different between groups; however, genotoxicity measures continue to show subtle, mixed results. CONCLUSION: Persistent urine uranium elevations continue to be observed more than 12 years since first exposure. Despite this, renal and other clinical abnormalities were not observed, likely due to the 'relatively' low uranium burden in this cohort compared to historical uranium-exposed occupational groups. Continuing surveillance is indicated, however, due to the on-going nature of the exposure. These results are an important finding in light of the on-going controversy regarding health effects observed in soldiers of the Gulf War and other conflicts, whose uranium exposure assessment is unable to be accurately determined.
OBJECTIVE: To relate medical surveillance outcomes to uranium biomonitoring results in a group of depleted uranium (DU)-exposed, Gulf War I veterans. METHODS: Thirty-two veterans of Gulf War I who were victims of 'friendly fire' involving DU weapons, in whom exposure assessment can accurately be measured, had urine uranium concentrations determined using ICP-MS technology. Clinical laboratory parameters were measured and related to urine uranium concentrations. Data were examined by stratifying the cohort into a low U group, <0.10 mug/g creatinine versus a high U group, >/=0.10 mug/g creatinine and assessing differences between groups. RESULTS: Over a decade after first exposure, soldiers possessing embedded DU fragments continue to excrete elevated concentrations of uranium in urine. No clinically significant uranium related health effects were observed in blood count, blood chemistries including renal markers, neuropsychological measures, and semen quality or genotoxicity measures. Markers of early changes in renal glomerular and tubular function were not statistically different between groups; however, genotoxicity measures continue to show subtle, mixed results. CONCLUSION: Persistent urine uranium elevations continue to be observed more than 12 years since first exposure. Despite this, renal and other clinical abnormalities were not observed, likely due to the 'relatively' low uranium burden in this cohort compared to historical uranium-exposed occupational groups. Continuing surveillance is indicated, however, due to the on-going nature of the exposure. These results are an important finding in light of the on-going controversy regarding health effects observed in soldiers of the Gulf War and other conflicts, whose uranium exposure assessment is unable to be accurately determined.
Authors: A P Gilman; D C Villeneuve; V E Secours; A P Yagminas; B L Tracy; J M Quinn; V E Valli; M A Moss Journal: Toxicol Sci Date: 1998-01 Impact factor: 4.849
Authors: J P O'Neill; L M Sullivan; J K Booker; B S Pornelos; M T Falta; C J Greene; R J Albertini Journal: Environ Mol Mutagen Date: 1989 Impact factor: 3.216
Authors: Melissa A McDiarmid; Susan Engelhardt; Marc Oliver; Patricia Gucer; P David Wilson; Robert Kane; Michael Kabat; Bruce Kaup; Larry Anderson; Dennis Hoover; Lawrence Brown; Barry Handwerger; Richard J Albertini; David Jacobson-Kram; Craig D Thorne; Katherine S Squibb Journal: J Toxicol Environ Health A Date: 2004-02-27
Authors: D R Robinson; K Goodall; R J Albertini; J P O'Neill; B Finette; M Sala-Trepat; E Moustacchi; A D Tates; D M Beare; M H Green Journal: Mutat Res Date: 1994 Oct-Dec Impact factor: 2.433
Authors: A C Miller; W F Blakely; D Livengood; T Whittaker; J Xu; J W Ejnik; M M Hamilton; E Parlette; T S John; H M Gerstenberg; H Hsu Journal: Environ Health Perspect Date: 1998-08 Impact factor: 9.031
Authors: Carrie D Dorsey; Susan M Engelhardt; Katherine S Squibb; Melissa A McDiarmid Journal: Environ Health Perspect Date: 2009-02-25 Impact factor: 9.031
Authors: Rebecca Shelley; Nam-Soo Kim; Patrick J Parsons; Byung-Kook Lee; Jacqueline Agnew; Bernard G Jaar; Amy J Steuerwald; Genevieve Matanoski; Jeffrey Fadrowski; Brian S Schwartz; Andrew C Todd; David Simon; Virginia M Weaver Journal: J Expo Sci Environ Epidemiol Date: 2013-04-17 Impact factor: 5.563
Authors: Yan Li; Hua Yu; Siqian Zheng; Yang Miao; Shi Yin; Peng Li; Ying Bian Journal: Int J Environ Res Public Health Date: 2016-03-22 Impact factor: 3.390